157 related articles for article (PubMed ID: 38445358)
1. Somatic CDKN2A copy number variations are associated with the prognosis of esophageal squamous cell dysplasia.
Fan Z; Zhou J; Tian Y; Qin Y; Liu Z; Gu L; Dawsey SM; Wei W; Deng D
Chin Med J (Engl); 2024 Apr; 137(8):980-989. PubMed ID: 38445358
[TBL] [Abstract][Full Text] [Related]
2. Feasibility of using P16 methylation as a cytologic marker for esophageal squamous cell carcinoma screening: A pilot study.
Fan Z; Qin Y; Zhou J; Chen R; Gu J; Li M; Zhou J; Li X; Lin D; Wang J; Deng D; Wei W
Cancer Med; 2022 Nov; 11(21):4033-4042. PubMed ID: 35352503
[TBL] [Abstract][Full Text] [Related]
3. Clinical and Genomic Analysis of Patients with Short Survival after Surgery for Esophageal Squamous Cell Carcinoma.
Gao L; Guo RY; Lu H; Shi ZH; Liu JF
Dig Dis; 2023; 41(3):353-361. PubMed ID: 36412562
[TBL] [Abstract][Full Text] [Related]
4. High-resolution genomic alterations in Barrett's metaplasia of patients who progress to esophageal dysplasia and adenocarcinoma.
Sepulveda JL; Komissarova EV; Kongkarnka S; Friedman RA; Davison JM; Levy B; Bryk D; Jobanputra V; Del Portillo A; Falk GW; Sonett JR; Lightdale CJ; Abrams JA; Wang TC; Sepulveda AR
Int J Cancer; 2019 Nov; 145(10):2754-2766. PubMed ID: 31001805
[TBL] [Abstract][Full Text] [Related]
5. Development of esophageal squamous cell cancer in patients with FAMMM syndrome: Two clinical reports.
van der Wilk BJ; Noordman BJ; Atmodimedjo PN; Dinjens WNM; Laheij RJF; Wagner A; Wijnhoven BPL; van Lanschot JJB
Eur J Med Genet; 2020 Mar; 63(3):103840. PubMed ID: 31923587
[TBL] [Abstract][Full Text] [Related]
6. Absence of NOTCH1 mutation and presence of CDKN2A deletion predict progression of esophageal lesions.
Liu M; Liu Y; Zhou R; Liu Z; Guo C; Xu R; Li F; Liu A; Yang H; Zhang S; Shen L; Duan L; Wu Q; Zhao M; Su H; Liu F; Pan Y; Cai H; He Z; Ke Y
J Pathol; 2022 Sep; 258(1):38-48. PubMed ID: 35612571
[TBL] [Abstract][Full Text] [Related]
7. [Distribution of esophageal squamous cell cancer and precursor lesions in high-risk areas, Linzhou in Henan province and Feicheng in Shandong province of China, 2005-2009].
Wang M; Hao C; Zhao D; Li B; Wang J; Lei F; Zhou R; Ma S; Ma Q; Li Y; Feng H; Li X; Wei W
Zhonghua Yu Fang Yi Xue Za Zhi; 2015 Aug; 49(8):677-82. PubMed ID: 26733024
[TBL] [Abstract][Full Text] [Related]
8. A genetic variant in CDKN2A/2B locus was associated with poor prognosis in patients with esophageal squamous cell carcinoma.
Ghobadi N; Mehramiz M; ShahidSales S; Rezaei Brojerdi A; Anvari K; Khazaei M; Rezayi M; Sadegh Khorrami M; Joudi-Mashhad M; Ramshini H; Ahmadi-Simab S; Moradi A; Hassanian SM; Ghayour-Mobarhan M; Boroushaki MT; Ferns GA; Avan A
J Cell Physiol; 2019 Apr; 234(4):5070-5076. PubMed ID: 30238987
[TBL] [Abstract][Full Text] [Related]
9. An Old Story Retold: Loss of G1 Control Defines A Distinct Genomic Subtype of Esophageal Squamous Cell Carcinoma.
Wang Q; Bai J; Abliz A; Liu Y; Gong K; Li J; Shi W; Pan Y; Liu F; Lai S; Yang H; Lu C; Zhang L; Chen W; Xu R; Cai H; Ke Y; Zeng C
Genomics Proteomics Bioinformatics; 2015 Aug; 13(4):258-70. PubMed ID: 26386145
[TBL] [Abstract][Full Text] [Related]
10. Consistent and differential genetic aberrations between esophageal dysplasia and squamous cell carcinoma detected by array comparative genomic hybridization.
Shi ZZ; Shang L; Jiang YY; Hao JJ; Zhang Y; Zhang TT; Lin DC; Liu SG; Wang BS; Gong T; Zhan QM; Wang MR
Clin Cancer Res; 2013 Nov; 19(21):5867-78. PubMed ID: 24009147
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide copy number variation analysis identified ANO1 as a novel oncogene and prognostic biomarker in esophageal squamous cell cancer.
Yu Y; Cao J; Wu W; Zhu Q; Tang Y; Zhu C; Dai J; Li Z; Wang J; Xue L; Zhen F; Liu J; Huang C; Zhao F; Zhou Y; Wen W; Pan X; Wei H; Zhu Y; He Y; Que J; Wang W; Luo J; Xu J; Chen L
Carcinogenesis; 2019 Oct; 40(10):1198-1208. PubMed ID: 31050728
[TBL] [Abstract][Full Text] [Related]
12. Landscape of copy number aberrations in esophageal squamous cell carcinoma from a high endemic region of South Africa.
Brown J; Stepien AJ; Willem P
BMC Cancer; 2020 Apr; 20(1):281. PubMed ID: 32252688
[TBL] [Abstract][Full Text] [Related]
13. NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma.
Galipeau PC; Li X; Blount PL; Maley CC; Sanchez CA; Odze RD; Ayub K; Rabinovitch PS; Vaughan TL; Reid BJ
PLoS Med; 2007 Feb; 4(2):e67. PubMed ID: 17326708
[TBL] [Abstract][Full Text] [Related]
14. Recurrent copy number alterations involving EGFR, CDKN2A, and CCND1 in oral premalignant lesions.
Jäwert F; Fehr A; Öhman J; Stenman G; Kjeller G
J Oral Pathol Med; 2022 Jul; 51(6):546-552. PubMed ID: 35488777
[TBL] [Abstract][Full Text] [Related]
15. Genetic status of cell cycle regulators in squamous cell carcinoma of the oesophagus: the CDKN2A (p16(INK4a) and p14(ARF) ) and p53 genes are major targets for inactivation.
Smeds J; Berggren P; Ma X; Xu Z; Hemminki K; Kumar R
Carcinogenesis; 2002 Apr; 23(4):645-55. PubMed ID: 11960918
[TBL] [Abstract][Full Text] [Related]
16. CDKN2A copy number and p16 expression in malignant pleural mesothelioma in relation to asbestos exposure.
Kettunen E; Savukoski S; Salmenkivi K; Böhling T; Vanhala E; Kuosma E; Anttila S; Wolff H
BMC Cancer; 2019 May; 19(1):507. PubMed ID: 31138176
[TBL] [Abstract][Full Text] [Related]
17. Genetic Alterations in Esophageal Tissues From Squamous Dysplasia to Carcinoma.
Liu X; Zhang M; Ying S; Zhang C; Lin R; Zheng J; Zhang G; Tian D; Guo Y; Du C; Chen Y; Chen S; Su X; Ji J; Deng W; Li X; Qiu S; Yan R; Xu Z; Wang Y; Guo Y; Cui J; Zhuang S; Yu H; Zheng Q; Marom M; Sheng S; Zhang G; Hu S; Li R; Su M
Gastroenterology; 2017 Jul; 153(1):166-177. PubMed ID: 28365443
[TBL] [Abstract][Full Text] [Related]
18. Integrated clinicomolecular characterization identifies RAS activation and CDKN2A deletion as independent adverse prognostic factors in cancer of unknown primary.
Bochtler T; Reiling A; Endris V; Hielscher T; Volckmar AL; Neumann O; Kirchner M; Budczies J; Heukamp LC; Leichsenring J; Allgäuer M; Kazdal D; Löffler H; Weichert W; Schirmacher P; Stenzinger A; Krämer A
Int J Cancer; 2020 Jun; 146(11):3053-3064. PubMed ID: 31970771
[TBL] [Abstract][Full Text] [Related]
19. Prognostic biomarker study in patients with clinical stage I esophageal squamous cell carcinoma: JCOG0502-A1.
Oshima K; Kato K; Ito Y; Daiko H; Nozaki I; Nakagawa S; Shibuya Y; Kojima T; Toh Y; Okada M; Hironaka S; Akiyama Y; Komatsu Y; Maejima K; Nakagawa H; Onuki R; Nagai M; Kato M; Kanato K; Kuchiba A; Nakamura K; Kitagawa Y
Cancer Sci; 2022 Mar; 113(3):1018-1027. PubMed ID: 34962019
[TBL] [Abstract][Full Text] [Related]
20. Genome wide copy number analyses of superficial esophageal squamous cell carcinoma with and without metastasis.
Wang P; Shan L; Xue L; Zheng B; Ying J; Lu N
Oncotarget; 2017 Jan; 8(3):5069-5080. PubMed ID: 27974698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
